A study published this week in the peer-reviewed journal Scientific Reports examined the long-term impacts of having shingles ...

Omeros' performance has consistently failed to meet expectations, raising concerns about its future prospects. Read more to ...

The case involved a 59-year-old man with stage IIIA right lung adenocarcinoma who underwent surgery in 2021, followed by ...

Omeros Corporation ( ($OMER) ) has released its Q2 earnings. Here is a breakdown of the information Omeros Corporation presented to its investors.

The FDA is expected to decide on treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy. The FDA is reviewing a nasal spray ...

The management of lupus nephritis (LN) and concomitant thrombotic microangiopathy (TMA), with or without antiphospholipid antibodies (aPL), remains controversial, and few studies are available to ...

In conclusion, our findings of high insulin and C-peptide levels in patients with cerebral microangiopathy, and especially in those with lacunes, as opposed to patients with large-vessel disease and ...

The Thrombotic Microangiopathy drugs in development market research report provides comprehensive information on the therapeutics under development for Thrombotic Microangiopathy, complete with ...

PHILADELPHIA — Patients with early thrombotic microangiopathy may have reduced allograft function and decreased allograft and patient survival with long-term follow-up.“There are specific risk ...

Patients who had IgAN with vs without microangiopathy had worse survival, investigators reported. Microangiopathy is frequently observed in IgA nephropathy. Investigators believe it may help predict ...